Got a few of these today after a hc poster suggested I take a close look at NAN. Excellent cash position and looks like good profits are very close and would rather invest in stocks in an uptrend rather than catch falling daggers. An article from a few weeks ago out of interest.
-One medical device company all of the brokers agree is a buy is Nanosonics - even if only a couple of them cover the stock.
The great thing about Nanosonics is that it is in the relatively early days of distributing its Trophon device, which quickly and easily sterilises ultrasound probes using a fine hydrogen peroxide mist.
With a strong first mover advantage and solid intellectual property protection, Nanosonics has effectively invented a better mousetrap that enables hospitals to dispose of some nasty chemicals normally used to disinfect the probes and reduce the chances of deadly cross-infections while dramatically improving productivity.
Nanosonics chief executive Dr Ron Weinberger said the device distributor GE Healthcare was particularly keen to continue the relationship and a recent US trip to talk to analysts had resulted in some US institutions entering the share register.
The obvious product extension to an ear, nose and throat probe is under development and would allow hospitals to completely eradicate the use of the harsh chemical cleaners, which require staff to use special clothing.
Another of several targets down the track is the dentist's surgery, which uses cameras and other electronic probes that need to be disinfected without the use of heat.
But for now all of the focus is on continuing to roll out Trophon which will produce multiple revenue streams through the supply of consumables, accessories and service contracts.
With the Sydney manufacturing arm capable of greatly increasing Trophon output and word of mouth building among those who use and own the 500,000 ultrasound machines in the world, Nanosonics remains a buy despite a solid rise in the share price.
John Beveridge The Herald Sun
NAN Price at posting:
59.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)